维普期刊资源整合服务平台（V6.5）

38篇 您的检索式：作者名="Stam ML"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Towards targeted therapy for infant acute lymphoblastic leukaemia显示文摘	Stam RW den Boer ML Pieters R	2006	Br J Haematol2006，132，5：	1
2	Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemia显示文摘	Ronald W Stam ML den Boer ME	2003	Blood2003，101，4：	1
3	Targeting FLT3 in primary MLL gene-rearranged infant acute lymphoblastic leukemia 显示文摘	Stam RW den Boer ML Schneider P	2005	Blood2005，106，7：	1
4	Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t(12; 21) pediatric ALL显示文摘	Stams WA den Boer ML Beverloo HB	2003	Blood2003，101，7：	1
5	Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemia 显示文摘	Stam RW den Boer ML Meijerink JP	2003	Blood2003，101，4：	1
6	Silencing of the tumor suppressor gene FHIT is highly characteristic for MLL gene rear- ranged infant acute lymphoblastic leukemia 显示文摘	Stam RW den Boer ML Passier M	2006	Leukemia2006，20，2：	1
7	Perioperative nesiritide versus milrinone in high-risk coronary artery bypass graft patients显示文摘	Brackbill ML Stam MD Schuller-Williams RV	2007	Ann Pharmacother2007，41，：	1
8	Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemia显示文摘	Stam RW den Boer ML Meijerink JP	2003	Blood2003，101，4：	1
9	Towards targeted therapy for infant acute lymphoblastie leukaemia显示文摘	Stam RW den Boer ML Pieters R	2006	Br J Haematol2006，132，5：	1
10	Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t(12;21)+pediatric ALL显示文摘	Stams WA Den Boer ML Beverloo HB	2003	Blood2003，101，7：	1
11	Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leuke显示文摘	Stam RW Boer ML Meijerink JP	2003	Blood2003，101，：	1
12	Expression levels of TEL,AML1,and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia显示文摘	Stams WA Den Boer ML Beverloo HB	2005	Clin Cancer Res2005，11，8：	1
13	Silencing of the tumor suppressor gene FHIT is highly characteristic for MLL gene rearranged infant acute lymph leukemia显示文摘	Stam RW den Boer ML Passier MM	2006	Leukemia2006，20，2：	1
14	Multidrug resistance genes in infant acute lymp hloblastic leukemia:Ara-C is not a substrate for t hle breast cancer resistance protein显示文摘	Stam RW van den Hleuvel-Eibrink MM den Boer ML	2004	Leukemia2004，18，1：	1
15	Silencing of the tumor suppressor gene FHIT is highly characteristic for MLL gene rearranged infant acute lymph-oblastic leukemia显示文摘	Stam RW den Boer ML Passier MM	2006	Leukemia2006，20，2：	1
16	Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lym- phobalastic leukemia 显示文摘	Stam RW den Boer ML Meijerink JP	2003	Blood2003，101，4：	1
17	Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t ( 12;21 ) + pediatric ALL 显示文摘	Stams WA den Boer ML Beverloo HB	2003	Blood2003，101，7：	1
18	Incidence of additional genetic changes in the TEL and AMLI genes in DCOG and COALL-treated t ( 12 ; 21 )-positive pediatric ALL, and their relation with drug sensitivity and clinical outcome 显示文摘	Stams WA Beverloo HB den Boer ML	2006	Leukemia2006，20，3：	1
19	Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t(12;21) t pediatric ALL显示文摘	Stams WA den Boer ML Beverloo HB	2003	Blood2003，101，7：	1
20	Silencing of the tumor suppressor gene FHIT is highly characteristic for MLL gene rear- ranged infant acute lymphoblastic leukemia 显示文摘	Stam RW den Boer ML Passier MM	2006	Leukemia2006，20，2：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示